Gilead stock edged lower late Thursday after the biotech company reported adjusted earnings of $1.87 per share on $6.217 billion in second-quarter sales.
On average, analysts polled by FactSet expected Gilead Sciences (GILD) to earn $1.74 a share on $6.08 billion in sales.
In the year-earlier period, Gilead earned $1.11 per share and reported $5.14 billion in sales.
For the year, Gilead narrowed its EPS range to $6.90-$7.25 from $6.75-7.45, with the midpoingt slightly lower.
Analysts called for adjusted profit of $7.11 per share and $24.67 billion in sales.
In after-hours trading on the stock market today, Gilead stock fell 0.5%. GILD stock is forming a flat base with a buy point at 70.21, according to MarketSmith.com. Gilead stock narrowly topped that entry during the regular session before pulling back to close down 0.3% 69.83.
https://www.investors.com/news/technology/gilead-stock-gilead-earnings-q2-2021/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.